Gemcitabine (2',2'-difluorodeoxy- cytidine, dFdC) is an analog of deoxycytidine. It is transformed to the active triphosphate (dFdCTP) after intracellular phosphorylation. Gemcitabine monophosphate is inserted into the DNA and inhibits DNA elongation as a false nucleotide. In contrast to other antimetabolites, an additional, altered nucleotide is inserted behind dFdC inhibiting repair mechanisms (masked chain termination).
Gemcitabine / M. Tani, L. Alinari, A. Broccoli, E. Derenzini, M. Fina, L. Gandolfi, E. Marchi, C. Pellegrini, V. Stefoni, F. Venturini, P.L. Zinzani. - In: HEMATOLOGY MEETING REPORTS. - ISSN 1970-7339. - 3:1(2009), pp. 90-93. ((Intervento presentato al convegno Now we know T-cell lymphomas better tenutosi a Bologna nel 2009 [10.4081/hmr.v3i1.542].
Gemcitabine
E. Derenzini;
2009
Abstract
Gemcitabine (2',2'-difluorodeoxy- cytidine, dFdC) is an analog of deoxycytidine. It is transformed to the active triphosphate (dFdCTP) after intracellular phosphorylation. Gemcitabine monophosphate is inserted into the DNA and inhibits DNA elongation as a false nucleotide. In contrast to other antimetabolites, an additional, altered nucleotide is inserted behind dFdC inhibiting repair mechanisms (masked chain termination).File | Dimensione | Formato | |
---|---|---|---|
542-Article Text-2083-1-10-20090611.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
76.26 kB
Formato
Adobe PDF
|
76.26 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.